HAWKINS WILLIAM A — SEC Form 4 filings
SEC reporting owner CIK 1106508. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-06 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bioventus Inc. (BVS) | Director | 4 | — | — | 9 |
| BIOGEN INC. (BIIB) | Director | 3 | — | — | 3 |
| MIMEDX GROUP, INC. (MDXG) | Director | 3 | — | — | 3 |
Form 4 filings — HAWKINS WILLIAM A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | MIMEDX GROUP, INC. (MDXG) | Grant/award (A): 50,913 @ $3.64 | EDGAR |
| 2026-06-11 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 1,505 @ $0 | EDGAR |
| 2026-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 39,789 @ $0 · Option exercise (M): 39,789 (derivative) @ $0 · Grant/award (A): 30,994 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | MIMEDX GROUP, INC. (MDXG) | Grant/award (A): 28,609 @ $6.47 | EDGAR |
| 2025-06-18 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 2,370 @ $0 | EDGAR |
| 2025-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 39,789 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 1,340 @ $0 | EDGAR |
| 2024-06-13 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 26,493 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | MIMEDX GROUP, INC. (MDXG) | Grant/award (A): 23,190 @ $7.26 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1106508 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →